WHO ICTRP trial
Study for development of new treatment for antibody mediated rejection in organ…
JPRN-UMIN000030525 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000030525 |
|---|---|
| Public title | Study for development of new treatment for antibody mediated rejection in organ transplantation |
| Scientific title | Study for development of new treatment for antibody mediated rejection in organ transplantation - Development of new treatment for antibody mediated rejection |
| Primary sponsor | Tokyo Women's Medical University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | organ failure |
| Interventions | Administration with rituximab 375 mg/m2 once or twice |
| Registration date | Sep 1, 2018 |
| Target size | 41 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: